Abstrakt: |
A recent study conducted by the China Academy of Chinese Medical Sciences explores the potential of traditional Chinese medicine (TCM) in treating hematologic malignancies, such as leukemia and multiple myeloma. The study focuses on a newly identified form of cell death called ferroptosis, which is characterized by lipid peroxidation and elevated iron levels. The researchers suggest that TCM may modulate hematologic malignancies through the ferroptosis pathway, making it a potential therapeutic target. The study aims to enhance treatment efficacy by understanding the mechanisms of ferroptosis and the role of TCM in preventing and treating hematologic malignancies. [Extracted from the article] |